Brief Overview on Sustained Release Theophylline (SRT): An Older Drug for COPD | Chapter 11 | Novel Aspects on Pharmaceutical Research Vol. 3

 This branch aimed to stress the value of specific a drug which needs to be employed as it has withstood the test momentary and the efficacy and appropriate inclusion concerning this drug may still be the elixir of COPD situation. With the advent of more recent drugs, the treatment of incessant obstructive pulmonary ailment (COPD) is undergoing a tremendous and active revolution. Newer drugs, mainly inhalational, with better operation and reduced side-belongings, are being introduced regularly in the administration of this alternatively difficult- to-treat ailment. We believe that the principle that states that the development of new drugs does not diminish the dispassionate advantage of earlier used one applies to SRT. We try to emphasise the significance of Sustained- Released Theophylline (SRT) in the administration of COPD in this abstract. The endeavour is to orderly emphasize the myriad conduct of SRT which specify relief by diversified means to patients in Acute exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD).

Author(s) Details:

A. Sharma,
National Institute of Chest Physician, National Institute of Tuberculosis and Respiratory Diseases (NITRD), New Delhi–110030, India.

A. R. Kansal,
National Institute of Tuberculosis and Respiratory Diseases (NITRD), New Delhi–110030, India.

Please see the link here: https://stm.bookpi.org/NAPR-V3/article/view/10886